Clinical Trials Logo

Filter by:
NCT ID: NCT04355637 Completed - Clinical trials for Coronavirus Infection

Inhaled Corticosteroid Treatment of COVID19 Patients With Pneumonia

Start date: April 21, 2020
Phase: Phase 4
Study type: Interventional

Randomized, prospective, controlled open label clinical trial aimed at investigating if the addition of inhaled corticosteroids (budesonide) reduces treatment failure (defined as a composite variable by the initiation of treatment with high flow-O2 therapy, non-invasive or invasive ventilation, systemic steroids, use of biologics (anti IL-6 or anti IL-1) and/or death) according to hospital standard of care guidance) at day 15 after initiation of therapeutic intervention.

NCT ID: NCT04355013 Completed - Clinical trials for Temperature Change, Body

Temperature Monitoring in Cardiac Surgery: Agreement Between Different Clinical Methods

Start date: September 28, 2016
Phase:
Study type: Observational

Observational study to compare core temperatures obtained by 6 methods in patients undergoing cardiac surgery under cardiopulmonary bypass.

NCT ID: NCT04353817 Completed - Cystic Fibrosis Clinical Trials

A Study Evaluating Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor in Subjects 6 Through 11 Years of Age With Cystic Fibrosis and F/MF Genotypes

Start date: June 19, 2020
Phase: Phase 3
Study type: Interventional

This study will evaluate the efficacy and safety of elexacaftor (ELX) / tezacaftor (TEZ) / ivacaftor (IVA) triple combination (TC) in subjects 6 through 11 years of age with cystic fibrosis (CF) who are heterozygous for F508del and a minimal function (MF) mutation (F/MF genotypes).

NCT ID: NCT04353791 Completed - Clinical trials for Ulcerative Colitis Chronic Moderate

Study of OST-122 in Patients With Moderate to Severe Ulcerative Colitis

Start date: September 16, 2020
Phase: Phase 1/Phase 2
Study type: Interventional

A Phase Ib/IIa to evaluate the safety and tolerability of oral treatment with OST-122 in patients with moderate to severe ulcerative colitis over 28 days. This trial will also explore pharmacokinetics (PK) profile and preliminary therapeutic efficacy associated with OST-122 through biomarker analysis and clinical, endoscopic and histologic assessments.

NCT ID: NCT04353128 Completed - Covid19 Clinical Trials

Efficacy of Melatonin in the Prophylaxis of Coronavirus Disease 2019 (COVID-19) Among Healthcare Workers.

MeCOVID
Start date: April 20, 2020
Phase: Phase 2/Phase 3
Study type: Interventional

There is an urgent need to evaluate interventions that can prevent the infection with SARS-CoV 2 of healthcare workers at risk. Melatonin is an inexpensive and safe product with protective effect in both bacterial and viral infections likely due to its anti-inflammatory and anti-oxidative effects. This randomized controlled trial seeks to evaluate is efficacy as a prophylaxis in healthcare workers exposed to the virus in their clinical practice.

NCT ID: NCT04352920 Completed - Muscle Injury Clinical Trials

Vacuum Myofascial Therapy Device in Treatment of Muscle Fibrosis

Physium
Start date: August 1, 2019
Phase: N/A
Study type: Interventional

We present the case of a 24-year-old professional soccer player, with no personal history of interest, who came to the X-Ray diagnosis service due to severe pain in the right quadriceps muscle after a 10-month evolution of muscle rupture occurred during sports practice.

NCT ID: NCT04352647 Completed - Clinical trials for Urinary Incontinence

Observational Study on the Prevalence of Urinary Incontinence in Federates Athletes.

Start date: January 10, 2020
Phase:
Study type: Observational [Patient Registry]

To study the prevalence of urinary incontinence (UI) in female athletes from Castilla y León, as well as the category of athletics with the highest number of losses, the most incident risk factors and the bio-psycho-social consequences that it leads to.

NCT ID: NCT04352049 Completed - Clinical trials for Anesthesia; Functional

Assessment Through Transcutaneous Brain Oximetry (NIRS) of Two Preoxygenation Techniques

Start date: April 15, 2012
Phase: N/A
Study type: Interventional

Preoxygenation techniques is currently considered a standard of care, but how they influence cerebral oxygenation remains largely unknown. In this study, the investigators compare three minutes tidal volume breathing versus eight vital capacity, deep breaths (8DB) technique. Forty-eight patients scheduled for surgery under general anesthesia were included in a randomized study design. The main endpoints were arterial partial pressure of O2 (PaO2) and regional cerebral oxygen saturation (rScO2 ; INVOS TM -5100- C) which were measured at baseline (T1), end of pre-oxygenation (T2) and after desaturation during apnoea to 95% (T3).

NCT ID: NCT04351893 Completed - Microtia Clinical Trials

Craniofacial Microsomia: Accelerating Understanding of the Significance and Etiology

CAUSE
Start date: February 23, 2018
Phase:
Study type: Observational

The CAUSE study is a multicenter study, with domestic (n=4) and international (n=6) study sites. Children and young adults (ages 0-18) who have microtia and/or craniofacial microsomia and their parents are invited to participate. Children and parents are asked to provide a DNA sample (blood or saliva) and are asked to upload a few photos of their face. Parents are asked a short interview. Participants are able to participate from home or at one of four domestic sites.

NCT ID: NCT04350853 Completed - Tooth Decay Clinical Trials

Surgical Extrusion for the Clinical Crown Lengthening: a 12-months Clinical Study

Start date: March 20, 2018
Phase: N/A
Study type: Interventional

This is a prospective study in which surgical extrusion of single-rooted teeth is carried out by the same operator in 15 consecutive patients. Main objective: to evaluate the soft tissue rebound of the teeth 1 year after the surgery. Null hypothesis (H0): surgical extrusion is not a predictable treatment for the restoration of single rooted teeth.